REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Snp Genetics Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Snp Genetics Co. Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company principally Research and Experimental Development On Natural Sciences and Engineering. The Company was founded on May 26, 2000 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on July 1, 2013.

Headquarters
1007.Sogang Univ, Sinsu-Dong, Mapo-Gu
Seoul; Seoul; Postal Code: 121-742

Contact Details: Purchase the Snp Genetics Co. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Snp Genetics Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Snp Genetics Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Snp Genetics Co. Ltd. report to view the information.
Incorporation Date:
2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Auditor
Subsidiaries
(주)에스엔피제네틱스
Company Performance
Financial values in the chart are available after Snp Genetics Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-45.35%▼
Total operating revenue
-45.34%▼
Operating profit (EBIT)
-45.93%▼
EBITDA
-80.33%▼
Net Profit (Loss) for the Period
-476.36%▼
Total assets
-5.69%▼
Total equity
-26.85%▼
Operating Profit Margin (ROS)
-1960.86%▼
Net Profit Margin
-3339.34%▼
Return on Equity (ROE)
-57.13%▼
Debt to Equity Ratio
45.85%▲
Quick Ratio
-1.39%▼
Cash Ratio
-0.06%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo